These results suggest that CB2 receptor contributes to the obesity-associated metabolic disorder by regulating the chronic inflammation associated with obesity [112], which is counterintuitive considering that in other inflammatory conditions CB2 agonists have proven to be beneficial [218]. The gene discussed is CNR2; the disease is obesity disorder.